ARF (ARF) plays a major role in the activation of p53 by oncogenic signals. The biochemical basis of this has not been fully elucidated. We report here that forced expression of p14 ARF enhances phosphorylation of p53 serine 15 (p53S15) in NIH3T3, IMR90 and MCF7 cells. Ectopic expression of the oncogenes c-myc, E2F1 and E1A, all of which activate p53 at least partially via ARF, lead to p53S15 phosphorylation in IMR90 cells. In addition, ectopic expression of p53 also results in p53S15 phosphorylation, suggesting that this is a common event in the ARFp53 tumor suppression system. Furthermore, p53-, p14 ARF -, c-myc-and E2F1-, but not E1A-, induced p53S15 phosphorylation was substantially reduced in AT fibroblasts (GM05823). Downregulation of ATM in MCF7 cells using RNA interference (RNAi) technology significantly attenuated p14 ARF -and p53-induced phosphorylation of p53S15. Ectopically expressed ARF in NIH3T3 cells induced ATM nuclear foci and activated ATM kinase. Functionally, ectopic expression of p14 ARF and c-myc inhibited the proliferation of IMR90 but not ATM null GM05823 cells, and p14 ARF -induced inhibition of MCF7 cell proliferation was significantly attenuated by downregulation of ATM by RNAi. Taken together, these data show a functional role for ATM in ARF-mediated tumor suppression.
Introduction
The INK4A/ARF locus on human chromosome 9p21 encodes two tumor suppressors, p16 INK4A and p14 ARF , by alternative splicing and use of different reading frames (Quelle et al., 1995) . They function in the retinoblastoma (Rb) and p53 tumor suppressor pathways, respectively (Serrano et al., 1993; Kamijo et al., 1997) .
The product of the alternative reading frame (ARF) of p16 INK4A (p14 in human and p19 in murine systems; referred to as ARF herein for generic statements) (Quelle et al., 1995; Stott et al., 1998) , stabilizes p53 in response to oncogenic signals. In primary fibroblasts, expression of oncogenic Ras activates p53 in an ARFdependent manner (Serrano et al., 1997; Palmero et al., 1998) . Expression of oncogenes such as c-myc, E1A, E2F1, v-Able and b-catenin in normal cells also leads to p53 activation through ARF (de Stanchina et al., 1998; Zindy et al., 1998; Cong et al., 1999; Dimri et al., 2000; Damalas et al., 2001) . Furthermore, transgenic mice heterozygous for p19 ARF engineered to express c-myc in B cells exhibit accelerated B-cell lymphomas; 80% of such tumors had lost the wild-type p19 ARF allele (Eischen et al., 1999) , lending in vivo support to the notion that ARF plays an essential role in p53 activation by hyperproliferation signals. While it remains unclear how ARF might sense oncogenic hyperproliferation signals, recent developments have revealed that c-myc and E2F1 induce upregulation of the death-associated protein (DAP) kinase, a calcium/calmodulin-regulated kinase, and DAP kinase activates p53 in an ARF-dependent manner (Raveh et al., 2001) .
ARF stabilizes p53 by interaction with Mdm2, the major player in p53 destabilization in vivo. Homozygous deletion of mdm2 results in embryonic lethality in mice, which is rescued by simultaneous deletion of p53 (Jones et al., 1995; Montes de Oca et al., 1995) . Mdm2 interacts with the N-terminal region of p53, which contains the acidic transcriptional activation domain. This interaction results in direct inhibition of the transcriptional activity of p53 (Momand et al., 1992) , suppression of the p300/CBP-mediated p53 acetylation that stabilizes p53 (Ito et al., 2001) , ligation of ubiqitins on p53 (Honda et al., 1997) and export of p53 from the nucleus into cytoplasmic proteasomes for degradation (Roth et al., 1998) . ARF interacts directly with Mdm2, thereby inhibiting the ubiquitin ligase activity of Mdm2 in vitro (Honda and Yasuda, 1999) and abolishing the inhibitory activity of Mdm2 on p53 acetylation (Ito et al., 2001) . Thus, the net result of ARF action is neutralization of the multi-faceted inhibitory effects of Mdm2 on p53.
Biochemically, how ARF antagonizes Mdm2 is not clear. The observation that ARF localizes to nucleoli led to the hypothesis that ARF sequesters Mdm2 into nucleolar structures, resulting in p53 stabilization Zhang and Xiong, 1999) . Subsequently, however, it was found that p14 ARF does not co-localize with Hdm2 (human Mdm2) inside the nucleoli, but rather outside these structures (Kashuba et al., 2003) , and it is the non-nucleolar ARF that stabilizes p53 (Llanos et al., 2001) . Thus, nucleolar ARF may have other functions that are unrelated to p53. Indeed, it was found that p14 ARF interacts with topoisomerase I in nucleoli (Olivier et al., 2003) and that nucleolar ARF inhibits ribosomal RNA processing, consistent with nucleoli as sites of ribosomal biosynthesis (Sugimoto et al., 2003) . The observations that p14 ARF resides together with Hdm2 and p53 outside nucleolar structures, and that ARF is capable of forming a ternary complex with Mdm2 and p53 Kashuba et al., 2003) indicate that the interaction with ARF does not lead to release of Mdm2 from p53. It is thus unclear how ARF activates p53, while p53 remains bound to Mdm2.
Modulation of the interaction between Mdm2 and p53 plays a major role in p53 activation in the cellular DNA damage response. ATM, a member of the PI3-kinase family, directly phosphorylates p53S15 in response to ionizing radiation and activates checkpoint kinase 2 (Chk2) (Zhou and Elledge, 2000) . Chk2 subsequently phosphorylates p53S20 (Hirao et al., 2000) . Phosphorylation of p53S15 and p53S20, two residues adjacent to and located in the Mdm2-binding region (residues 17-22), respectively, facilitates the dissociation of Mdm2 from p53 (Shieh et al., 1997; Chehab et al., 1999) . Furthermore, direct ATMmediated phosphorylation on S395 of Mdm2 promotes its degradation via the ubiquitin system (Michael and Oren, 2002) .
Evidence indicates that interaction between the ARF-Mdm2-p53 pathway activated by oncogenic signals and ATM-Mdm2-p53 signaling initiated by DNA damage exists. Although the cellular DNA damage response is intact without ARF (Kamijo et al., 1997) , ARF enhances DNA damage-induced apoptosis (de Stanchina et al., 1998) and is required for some forms of the DNA damage response (Khan et al., 2000) . Furthermore, p14
ARF has been observed in a complex containing HR6 and p53 in response to cisplatin and adriamycin treatment (Lyakhovich and Shekhar, 2003) . However, whether ATM plays a role in ARF-Mdm2-p53 activation is not clear.
We report here that ATM contributes to the tumorsuppressing functions of p14 ARF . Enforced expression of p14 ARF leads to ATM-dependent p53S15 phosphorylation, possibly mediated by inducing formation of ATM nuclear foci. Downregulation of ATM results in attenuation of ARF-induced p53S15 phosphorylation and releases ARF-induced inhibition of cell proliferation.
Results

Expression of p14
ARF leads to phosphorylation of p53S15
The fact that both the cellular DNA damage response and oncogenic stimuli target Mdm2 to stabilize p53 promoted us to investigate whether p14 ARF could utilize the DNA damage pathway to facilitate p53 activation. As phosphorylation of p53S15 is a typical event in the cellular DNA damage response (Zhou and Elledge, 2000), we first examined if p14 ARF could induce p53S15 phosphorylation. Since expression of ARF potently inhibits the proliferation of NIH3T3 cells ARF expression in a time-dependent manner ( Figure 1a ). As expected, p14
ARF stabilized p53 and thereby upregulated p21
CIP1
( Figure 1a ). Consistent with previous publications Zhang and Xiong, 1999) , p14 ARF was expressed exclusively in the nuclei (Figure 1b) . Interestingly, ectopically expressed p14 ARF also enhanced the phosphorylation of p53S15, which was not observed in control NIH3T3
Teton /pRevTet cells ( Figure 1a) . Kinetically, the phosphorylation of p53S15 peaks between 16 and 24 h of Dox treatment, decreasing by day 2 of Dox induction (Figure 1a) . The total p53 level follows a similar pattern, while p14
ARF is detected at 16 h and remains at peak level after 24-48 h of Dox induction (Figure 1a) . The reason for a decline in p53 and phosphorylated p53S15 in the context of ongoing high levels of p14 ARF is not clear, but may indicate activation of factors leading to p53 downregulation. This is consistent with the theme of network regulation on p53 protein stability, in that p53 protein upregulates its negative regulator Mdm2, leading to p53 degradation (Roth et al., 1998) .
To determine whether p14 ARF -induced phosphorylation of p53S15 is unique to NIH3T3 cells, we also studied this event in MCF7 and IMR90 cells. MCF7 cells were infected with either pBabe or pBabe-p14 ARF retrovirus for 48 h. Again, expression of p14 ARF increases the levels of p53S15 phosphorylation and total p53 protein (Figure 1d ). The same result was also obtained in IMR90 cells (Figure 2) . To ascertain at the cellular level whether cells expressing p14 ARF were those demonstrating phosphorylation of p53S15, MCF7 cells infected with pBabe or pBabep14 ARF were double stained with an anti-FLAG antibody (M2) for p14 ARF and a polyclonal antibody specific for phosphorylated p53S15. Cells expressing high levels of p14 ARF indeed exhibit enhanced phosphorylation on the serine 15 ( Figure 3D , 'e, f, g, h' for MCF7ConRNAi cells). The same results were also obtained in parental MCF7 cells (data not shown). Taken together, these data demonstrate that expression of p14 ARF induces the phosphorylation of p53S15 in multiple cells.
Expression of oncogenes induces phosphorylation of p53S15
The major established function of ARF is the activation of p53 in response to oncogenic signals. Several oncogenes, notably E1A, c-myc and E2F1, have been shown to activate p53 at least partially through ARF (de Stanchina et al., 1998; Zindy et al., 1998; Dimri et al., 2000) , suggesting that oncogenic signals may also induce p53S15 phosphorylation. To examine such a possibility, IMR90 cells were infected with an empty vector retrovirus or retroviruses expressing p53, p14 ARF , E1A, c-myc or E2F1. Ectopic expression of these transgenes was demonstrated (Figure 2 ). Compared to the empty vector retrovirus infection, exogenous p53, p14 ARF , E1A, c-myc and E2F1 all induce the phosphorylation of p53S15 (Figure 2) . Expression of p53, p14 ARF and E1A modestly upregulates p21 CIP1 ( Figure 2 ). Taken together, these data support the concept that oncogenic-stimulated p14 ARF leads to the phosphorylation of p53S15.
Expression of p53 induces phosphorylation of p53S15
Oncogenic signals can also activate p53 in ARFindependent manner. While how this is achieved remains largely unknown, it has been clearly demonstrated by several groups that these ARF-independent oncogenic pathways lead to p53 stabilization (de Stanchina et al., 1998; Zindy et al., 1998; Russell et al., 2002) . It is thus possible that a high level of p53 in these settings is sufficient to initiate p53S15 phosphorylation. In order to test this hypothesis, NIH3T3 cells expressing human p53 (detected by DO-1 antibody specific for human p53) in a Tet-inducible manner were constructed ( Figure 1c Teton / p14 ARF cells were induced with Dox (2 mg/ml) for the times indicated. Expression of p14 ARF , p53S15 phosphorylation (S15-P), p21 CIP1 (p21) and actin were determined by Western blot using an anti-FLAG antibody (M2) for p14 ARF and other specific antibodies. Teton /p53 (human) cells were induced to express p53 by Dox as indicated. The expression of p53 (human), S15-P, p21 and actin was determined using DO-1, an antibody specific for human p53, and other specific antibodies. (d) MCF7 cells were infected with pBabe, pBabe-p14 ARF and pBabep53 as indicated, or lanes 1, 2 and 3, respectively (inset). The expression of p14 ARF (ARF), p53 and p53S15 phosphorylation (S15-P) was determined by Western blot using specific antibodies (inset). The level of p53S15 phosphorylation in cells infected with p14 ARF or p53 is standardized against that in cells infected with pBabe. Experiments were repeated at least thrice ATM mediates p14
ARF -induced p53S15 phosphorylation
Since S15 of p53 is phosphorylated by ATM/ATR in the cellular DNA damage response, we reasoned that ATM could be a candidate kinase for the phosphorylation of S15 of p53 in response to p14 ARF signals. This is consistent with a recent report indicating a role for ARF in the cellular DNA damage response (Khan et al., 2000) . To determine if ATM plays a role in p14 ARF -induced phosphorylation on p53S15, IMR90 and AT fibroblasts (GM05823) were infected with an empty vector retrovirus or retrovirus expressing one of p53, p14 ARF , E1A, c-myc or E2F1. Comparable levels of these transgenes were expressed in IMR90 vs GM05823 cells (Figure 2 ). Compared to the empty vector retrovirus infection, levels of p53S15 phosphorylation were increased in IMR90 cells expressing p53, p14 ARF , c-myc and E2F1 (Figure 2) , and dramatically reduced in GM05823 cells (Figure 2 ). E1A-induced p53S15 phosphorylation was equally efficacious in IMR90 and in GM05823 cells (Figure 2) , indicating a role for other kinases, possibly ATR. Collectively, these observations support the notion that ATM is a candidate kinase in phosphorylation of p53S15 in response to ARF signals.
To exclude the possibility that other defects associated with the human AT fibroblast GM05823 cells might prevent p14
ARF from inducing p53S15 phosphorylation, and to examine whether the involvement of ATM in this process is unique to human fibroblast cells, we constructed MCF7 cells in which ATM expression was specifically downregulated by RNA interference (RNAi). MCF7 cells were infected with pRIH1 retrovirus expressing either ATM RNAi fragment 1 or 2. Blast searching confirmed that both RNAi fragments match to human ATM only. Compared to the empty vector (pRIH1) infection, pRIH1-ATMRNAi1 did not reduce ATM expression (data not shown). We thus used ATMRNAi1 as a negative control, and designated it as control RNAi (ConRNAi). In comparison with cells infected with ConRNAi, those infected with ATMRNAi2 (designated as ATMRNAi) display significantly reduced levels of ATM protein and mRNA ( Figure 3A and B). Densitometry analysis revealed that ATM protein and mRNA in ATMRNAi cells were expressed at levels of about 10% of those seen in ConRNAi cells (data not shown). Consistent with a major role of ATM in etoposide (ETOP)-induced p53 stabilization and p53S15 phosphorylation, downregulation of ATM severely impaired these events ( Figure 3A) . Taken together, these data clearly demonstrate the reduction of ATM in MCF7ATMRNAi cells.
Using MCF7ConRNAi and MCF7ATMRNAi cells, the role of ATM in p14 ARF -and p53-induced p53S15 phosphorylation was examined. Both cells were infected with an empty vector retrovirus or retrovirus expressing either p14 ARF or p53 ( Figure 3C and D). Both p14 ARF and p53 were expressed to comparable levels in MCF7ConRNAi vs MCF7ATMRNAi cells, as detected by immunofluorescent staining ( Figure 3D , e vs q for p14 ARF , i vs u for p53) and by Western blot (data not shown). Although by comparison to the level of p53S15 phosphorylation in pBabe-infected cells the relative increase of p53S15 phosphorylation (4-5 fold) induced by p14 ARF and p53 remains the same in MCF7ConRNAi vs MCF7ATMRNAi cells, the absolute levels of p53S15 phosphorylation induced by p14 ARF and p53 are significantly reduced in MCF7ATMRNAi cells ( Figure  3C and D, f vs r and j vs v). Taken together, the above data demonstrate a major role for ATM in phosphorylation of p53S15 in response to oncogene-p14 ARF signals.
ARF enhances ATM kinase activity and induces nuclear ATM foci ATM and ATR phosphorylate the S15 of p53 in the cellular DNA damage response. This is mediated by increasing ATM kinase activity and redistribution of , c-myc, E1A, E2F1, p53S15 phosphorylation (S15-P), p21
CIP1 and actin were determined by Western blot using specific antibodies as enumerated in Materials and methods. The second p53 bands are alternative p53 translation products (Yin et al., 2002) ATR in response to DNA damage (Tibbetts et al., 2000; Bakkenist and Kastan, 2003) . To support the observation that ATM may phosphorylate p53S15 by ARF signals, we examined ATM kinase activity in
NIH3T3
Teton /p14 ARF cells. These cells were chosen since ectopic ARF induces p53S15 phosphorylation ( Figure 1a ) and inhibits cell proliferation . Induction of p14 ARF enhanced ATM kinase ARF , p53 and S15-P in MCF7ConRNAi and MCF7ATMRNAi cells infected with pBabe or p14 ARF or p53 retrovirus was determined by immunostaining using specific antibodies. Nuclei were counterstained with DAPI. (a, e, q) were stained for ARF; (i, m, u) were stained for p53; (b, f, j, n, r, v) were stained for p53S15 phosphorylation (S15-P). Reduced DAPI staining in S15-P-positive nuclei may be attributable to apoptotic DNA degradation. Failure to detect p53 signals in panel (m) was due to the low level of endogenous p53 in these cells compared to cells expressing ectopic p53 activity in NIH3T3
Teton /p14 ARF cells, while Dox alone induced no changes in ATM kinase activity in NIH3T3
Teton /pRevTet (vector) cells (Figure 4a ). Compared to ETOP treatment, which induces an approximately fivefold increase in ATM kinase activity, induction of p14 ARF and p53 by Dox in NIH3T3 Teton / p14 ARF and NIH3T3 Teton /p53 cells, respectively, enhances ATM kinase activity about twofold (Figure 4b) .
To determine the possible mechanisms by which ARF activates ATM, we examined cellular localization of ATM in ARF-expressing vs control cells. Interestingly, induction of ARF in NIH3T3 Teton /p14
ARF cells led to the formation of ATM foci in nuclei ( Figure 5 ). This was not observed in mock-treated (without Dox) NIH3T3
Teton /p14 ARF cells or in individual Dox-treated NIH3T3 Teton /p14 ARF cells that did not express ARF (arrow, Figure 5 ), demonstrating the specificity of ATM foci for ARF-expressing cells. As radiation induces phosphorylation on S1981 of ATM, an event leading to ATM activation by dissociation of its kinase domain from FAT domain (Bakkenist and Kastan, 2003) , the formation of ATM foci induced by ARF might result from ATM conformation changes, leading to releasing ATM from FAT domain and thus ATM activation. Taken together, the above data demonstrate that ARF induces ATM activation, and suggest that this may be mediated by the formation of ATM foci in response to ARF signals.
ATM contributes to the tumor-suppressing functions of p14 ARF
The physiological function of ARF-p53 activation by oncogenic signals is to prevent cell proliferation and thereby suppress tumorigenesis. To determine whether ATM contributes to this function, we infected IMR90 and AT GM05823 fibroblasts with an empty retrovirus or retroviruses expressing p53, p14 ARF , E1A, c-myc or E2F1. Expression of these transgenes was confirmed (Figure 2 ). Infections were selected in puromycin to determine surviving cells, which were then stained with 0.1% crystal violet (Figure 6a ). Compared to the empty vector infection, expression of these transgenes substantially inhibited the proliferation of IMR90 cells, as expected (Figure 6a) . Interestingly, the ability of ectopically expressed p14 ARF and c-myc to inhibit cell proliferation, compared to the empty vector-infected cells, was significantly attenuated in GM05823 cells (Figure 6a ). This result also indirectly reveals that the reduced survival of IMR90 cells infected with p14 ARF or c-myc retrovirus when compared to pBabe infection (Figure 6a) was not due to low titers of p14 ARF or c-myc retrovirus, consistent with our titration experiments showing comparable titers for pBabe, p53, p14 ARF , E2F1, c-myc and E1A retrovirus (for detail, see Materials and methods). Overall, less GM05823 cells than IMR90 cells observed in this experiment may be attributed to the well-recognized reduced proliferation capacity associated with GM05823 cells. E1A still, however, potently blocks the proliferation of GM05823 cells, which agrees well with the observations that expression of E1A produces comparable levels of Teton /p14 ARF (ARF) cells were treated with or without Dox for 24 h as indicated. ATM was immunoprecipitated (IP) from 1 mg of total cell lysate protein using an anti-ATM antibody (Ab-3) and used to phosphorylate GST-p53 (2 mg) in vitro. GST-p53 was detected by a Western blot using an anti-p53 antibody (DO-1). P53S15 phosphorylation (S15-P) and IP ATM were examined by Western blot using specific antibodies. (b) NIH3T3
Teton /pRevTet (Vector) cells were treated with either ETOP at 100 mM for 4 h or Dox for 24 h. NIH3T3
Teton /p14 ARF (ARF) and NIH3T3
Teton /p53 (p53) cells were induced with Dox for 24 h. ATM kinase assay and detection of p53S15 phosphorylation, GST-p53 and IP ATM were then carried out as described in (a). The levels of p53S15 phosphorylation in ETOP or Dox-treated cells were standardized against those in the corresponding controls. Experiments were repeated thrice ARF retrovirus and selected in puromycin for 2-3 weeks. To avoid the possible artifacts associated with individual surviving cell colonies, a pooled population of surviving cells was harvested. In comparison to pBabe-infected cells, those surviving ectopic p14 ARF proliferated at a reduced rate (data not shown), suggesting the presence of ectopic ARF in the cells. Indeed, these cells did express ectopic p14 ARF (Figure 7a ). To examine ATM functions in those cells, we treated them with 100 mM ETOP and examined phosphorylation of p53 S15. As expected, ETOP-induced S15 phosphorylation in pBabe-infected MCF7ATMRNAi cells was ARF in the corresponding surviving cells was determined by Western blot using an anti-FLAG antibody (M2). (b) The corresponding surviving cells were treated with ETOP for 2 h and were examined for the expression of p53S15 phosphorylation (S15-P) or total p53 by Western blot using specific antibodies significantly reduced compared to pBabe-infected MCF7ConRNAi cells (Figure 7b) . Interestingly, the MCF7ConRNAi cells surviving ectopic p14 ARF also displayed substantial reduction in ETOP-induced p53S15 phosphorylation when compared to pBabeinfected MCF7ConRNAi cells (Figure 7b ), which was further reduced when the corresponding MCF7ATMR-NAi cells were analysed (Figure 7b) . The basal level of p53 in MCF7ConRNAi or MCF7ATMRNAi cells surviving ectopic p14
ARF did not differ significantly from that in both cells infected with pBabe (Figure 7b ). MCF7 cells are known to contain relatively high basal levels of p53 (Wu and Tang, unpublished observation) . Since ETOP-induced p53S15 phosphorylation is largely reduced in GM05823 and MCF7ATMRNAi cells (Figure 3A) , the reduction of ETOP-induced S15 phosphorylation in viable p14 ARF -expressing MCF7 cells is consistent with the concept that ATM function was attenuated in these cells.
Discussion
While p19
ARF clearly plays a major role in murine tumorigenesis, there might be some debate regarding the contribution of p14 ARF vs p16 INK4A in human tumorigenesis. However, mounting evidence accumulated recently reveals an important function of p14 ARF in blocking tumorigenesis in humans. By assaying deletion of the exon 1b (specific for p14 ARF ) or methylation of p14 ARF promoter, inactivation of p14 ARF has been detected in 33% of colon carcinomas (Burri et al., 2001) , 25% of oligodendrogliomas (Watanabe et al., 2001 ), 14% of breast cancers (Ho et al., 2001) , 26.5% of oral squamous cell carcinomas and 32-58% of gliomas (Ichimura et al., 2000; Shintani et al., 2001) . Mechanistically, p14 ARF bridges the RB and p53 tumor suppressors . However, ARF is not the only pathway leading to p53 activation by oncogenic signals.
The DNA damage and oncogene-ARF pathways activate p53 by targeting Mdm2. The data reported here reveal an intriguing link between the ATM-Mdm2-p53 DNA damage pathway and the oncogenic ARFMdm2-p53 cellular response. We have established that ATM contributes to the tumor suppressor functions of p14 ARF . Ectopic p14 ARF enhanced ATM kinase activity (Figure 4) . Reduction of ATM function attenuated p14 ARF mediated tumor suppression on AT fibroblasts (GM05823) and MCF7ATMRNAi cells (Figure 6 ), and cells surviving ectopic p14
ARF may have ATM function attenuated ( Figure 7 ). Our finding that ATM facilitates ARF-mediated tumor-suppressing function is consistent with a previous report showing that ARF plays a role in the premature senescence caused by loss of ATM in MEFs (Kamijo et al., 1999) . Since ATM sits far upstream in the cellular DNA damage response and coordinates p53 activation by phosphorylation of p53, Chk2 and Mdm2 (Zhou and Elledge, 2000) , utilization of ATM by p14 ARF may significantly promote the tumor suppression functions of ARF.
Phosphorylation of p53S15 by ARF would be expected to further destabilize the Mdm2-p53 complex. By direct interaction with p53, Mdm2 inhibits p53's transcriptional activity (Momand et al., 1992) , indicating a requirement for separation of p53 from Mdm2 for full-scale p53 activation. Mdm2 binds to the N-terminus of p53 between the residues 17 and 22 and phosphorylation at S15 and S20 facilitates p53 dissociation from Mdm2 (Shieh et al., 1997; Chehab et al., 1999) . However, since an ARF-Mdm2-p53 ternary complex was observed under certain conditions Kashuba et al., 2003) , it is unclear biochemically whether ARF directly destabilizes the Mdm2-p53 complex via interaction with Mdm2. Our findings suggest a mechanism whereby ARF could promote dissociation of Mdm2 from p53, in that ARF-induced ATM activation leads to p53S15 phosphorylation. This is consistent with the common cell biology phenomenon of exploitation of the same mechanism by multiple pathways.
We have shown here that ectopic p53 also leads to p53S15 phosphorylation, an observation consistent with a previous report (Russell et al., 2002) . As oncogenes can also activate p53 via ARF-independent pathways, this result indicates that an initial oncogenic signal may stabilize p53, through ARF-dependent or -independent pathways, leading to partial p53 activation. This induces modifications including S15 phosphorylation on p53, leading to its full-scale activation. However, this does not exclude the possibility that ARF or other oncogenic signal transducers may also directly activate these modification processes. These two scenarios are not mutually exclusive.
While both the cellular DNA damage response and oncogene-ARF signals activate ATM kinase, they may achieve this through different strategies. DNA damage activates ATM kinase by its dissociation from the FAT domain via phosphorylation of S1981 (Bakkenist and Kastan, 2003) . ARF signals, on the other hand, lead to formation of ATM nuclear foci ( Figure 5 ). This may be the result of or may result in a change in ATM conformation, leading to separation of ATM kinase domain from the FAT domain. Redistribution of a p53S15 kinase is also a strategy used by the cellular DNA damage response, in that it is generally believed that formation of ATR foci plays an essential role in p53S15 phosphorylation in the cellular DNA damage response (Tibbetts et al., 2000) . It is thus tempting to propose that the formation of ATM foci may be a major mechanism underlying ARF-induced ATM activation.
Our observation that the expression of E2F1, c-myc and E1A results in p53S15 phosphorylation is consistent with recent reports concerning E2F1 and c-myc (Rogoff et al., 2002; Vafa et al., 2002) . However, oncogenic stimuli-induced phosphorylation of p53S15 is complex. Expression of c-myc may induce DNA damage through generation of reactive oxygen species in normal human fibroblasts (NHF) (Vafa et al., 2002) . Indeed, the addition of the antioxidant N-acetyl-L-cysteine (NAC) significantly reduced the c-myc-induced p53S15 phosphorylation. However, NAC does not completely abolish c-myc-induced p53S15 phosphorylation and does not rescue c-myc-mediated inhibition of NHF cell proliferation (Vafa et al., 2002) , suggesting a role of p14 ARF in c-myc-induced p53S15 phosphorylation and the inhibition of NHF cell proliferation in this context. This is consistent with reports showing that the Myc signals activate p53-dependent tumor suppression at least partially via ARF Russell et al., 2002) . E2F1 was shown to induce p53S15 phosphorylation independently of ARF (Rogoff et al., 2002; Russell et al., 2002) . This does not exclude a role of ARF in E2F1-induced p53S15 phosphorylation in other situations, as E2F1 also induces ARF transcription Inoue et al., 1999; Dimri et al., 2000; Jin and Levine, 2001) . Our interpretation that E2F1 and c-myc induce the S15 phosphorylation in our system at least partially via the action of p14 ARF is consistent with these reports. Further, our interpretation is not mutually exclusive from the concepts of oncogene-induced ATM activation through DNA damage.
Regardless of what may ultimately be the major mechanism whereby oncogene expression activates ATM, we have shown here that ATM contributes to the tumor-suppressing functions of p14 ARF . Investigation of the underlying mechanism of this process will be of considerable interest in the field of ARF research.
Materials and methods
Materials, cell cultures and plasmids
The Tet-inducible cell line, 293 Teton , was from Clontech. IMR90 and the AT fibroblast cell line GM05823 were from ATCC and NIGMS Human Genetic Cell Repository, respectively. P14 ARF was cloned by PCR from C33A cervical carcinoma cells, the sequences confirmed and tagged with a C-terminal FLAG epitope. The C-terminal FLAG-tagged p14 ARF was subcloned into either pTET1 (a Tet-responsive vector) or a retroviral vector pBabe or a retroviral vector containing a Tet response element, pRevTet (Clontech). Plasmids expressing retroviral Gag-Pol (GP) and VSV-G proteins were from Stratagene.
Retroviral infection
Retroviral infection was performed as we have published, with some modifications . Retroviral plasmid DNA was co-transfected into 293T cells with the GP and VSV-G plasmids, using a calcium phosphate method for 48 h. A viruscontaining medium was then harvested and used to infect target cells in the presence of 10 mg/ml of polybrene (Sigma). To determine the retrovirus titer, a LacZ retrovirus without a mammalian selection marker was co-packed with a retroviral vector expressing a cDNA of interest at a ratio of 1 : 5 (LacZ:cDNA of interest). The virus was used to infect NIH3T3 cells for 36 h before staining for LacZ. 
Western blot
Cells lysate was prepared as previously described . The following primary antibodies were used: anti-FLAG (M2 at 3 mg/ml, Sigma), anti-p53 (FL-393 at 1 mg/ml, DO-1 at 0.5 mg/ml, Santa Cruz), anti-phosphorylated p53S15 (1 mg/ml, Cell Signaling), anti-actin (0.5 mg/ml, Santa Cruz), anti-p21 CIP1 (1 mg/ml, Santa Cruz) and anti-ATM (Ab-3, 2 mg/ ml, Oncogene Res. Prod).
Immunofluorescent detection of p53, p14
ARF and ATM Cells were fixed with 3% paraformaldehyde and incubated for 2 h with affinity-purified monoclonal anti-FLAG antibody (M2 at 1 : 50), anti-p53, anti-phospho-p53S15, or anti-ATM (Ab-3), followed by incubation with FITC-conjugated antimouse or Cy5-Donkey anti-rabbit IgG (Jackson Immnuno Research). Immunofluorescence was detected using a fluorescent microscope (Zeiss).
Silencing of endogenous ATM in MCF7 cells by RNAi
A novel retroviral vector, pRIH1, was constructed to direct the expression of an RNAi fragment by the human RNase P RNA H1 promoter, an RNA polymerase III promoter (Y Li and D Tang, unpublished data). The control ATM RNAi fragment (ConRNAi) used in these experiments was sense: GATCCC CGCACCAGTCCAGTATTGGCTTCAAG-AGAGCCAATA CTGGACTGGTGCTTTTTGGAAA and antisense: AGCTT TTCCAAAA-AGCACCAGTCCAGTATTGGCTCTCTTGA AGCCAATACTGGACTGGTGCGGG. The ATM RNAi fragment (ATMRNAi) was sense: GATCCCCTCTCAGCAA-CAGTGGTTAGTTCAAGAGACTAACCACTGTTGCTGA-GATTTTTGGAAA and antisense: AGCTTTTC-CAAAAA TCTCAGCAACAGTGGTTAGTCTCTTGAACTAACCAC TGTTGCTGAGAGGG. Nucleotides bolded and underlined are those of the sense and antisense sequences that will form a hairpin structure upon transcription inside cells. High titer retrovirus was packed and used to infect MCF7 cells.
Reverse transcription (RT)-PCR
Total RNA was isolated using Trizol (Life Technology) from MCF7ConRNAi and MCF7ATMRNAi cells according to the manufacturer's instruction. RT was carried out using an RT kit (Clontech). Specific primers used for ATM are: 5 0 -TCTTGATAAATGAGCAGTCAGC-3 0 (upper) and 5 0 -ACA CGTTCAGCTACTTTGTCG-3 0 (lower); for b-actin: 5 0 -AAC CCCAAGGCCAACCGCGAGAAG-3 0 (upper) and 5 0 -TCAT GAGGTAGTCAGTCAG-3 0 (lower). Amplification of actin up to 25 cycles was in the linear range (data not shown). Thus, RT-PCR of ATM and actin was achieved with 35 and 23 cycles, respectively.
ATM kinase assay
An N-terminal fragment (residues 1-40) of p53 was expressed as a GST fusion (GST-p53) protein in E. coli (Bl-21) as previously described (Tang et al., 1997) . ATM was immunoprecipitated from cell lysate using an anti-ATM antibody (Ab-3, Oncogene Res Prod) and used to phosphorylate GST-p53 (2 mg) in vitro at 301C for 30 min according to a published procedure (Chan et al., 2000) . After termination of the reaction by addition of 10 mM EDTA, protein G bead with bound ATM was precipitated by centrifugation (5000 g for 5 min). The supernatant was then incubated with glutathione Sepharose to precipitate GST-p53. The supernatant was combined with the protein G bead precipitates for analysis of precipitated ATM by a Western blot. Glutathione Sepharose-precipitated GST-p53 was analysed for p53S15 phosphorylation by a Western blot using a specific antibody (Cell Signaling).
